Quan, Walter, & Quan, Francine M. (January 2013).
Activity of dose-dense outpatient intravenous Interleukin-2 preceded by famotidine in metastatic clear cell cancer of the kidney.
Journal for Immunotherapy of Cancer,
(1:Suppl 1), p.29-29. Retrieved from
http://hdl.handle.net/10342/5536
Quan, Walter, and Quan, Francine M.
"Activity of dose-dense outpatient intravenous Interleukin-2 preceded by famotidine in metastatic clear cell cancer of the kidney". Journal for Immunotherapy of Cancer.
1:Suppl 1. (29-29.),
January 2013.
May 17, 2021.
http://hdl.handle.net/10342/5536.
Chicago:
Quan, Walter and Quan, Francine M,
"Activity of dose-dense outpatient intravenous Interleukin-2 preceded by famotidine in metastatic clear cell cancer of the kidney," Journal for Immunotherapy of Cancer 1, no.
Suppl 1 (January 2013),
http://hdl.handle.net/10342/5536 (accessed
May 17, 2021).
AMA:
Quan, Walter, Quan, Francine M.
Activity of dose-dense outpatient intravenous Interleukin-2 preceded by famotidine in metastatic clear cell cancer of the kidney. Journal for Immunotherapy of Cancer.
January 2013;
1(Suppl 1)
29-29. http://hdl.handle.net/10342/5536. Accessed
May 17, 2021.
